18-07-2021 12:00 via medpagetoday.com

Dexcom's CGM Interoperability Expands; Warfarin and Osteoporosis; Maine Bans PFAS

(MedPage Today) -- The FDA granted clearance for third-party apps to connect with Dexcom's interoperable continuous glucose monitors (CGMs) by integrating real-time CGM data into their digital health apps and devices.
Patients with diabetes regularly...
Read more »